InvestSMART

Sonic Healthcare Limited (ASX:SHL)

ALERT: Price-sensitive ASX Announcement for SHL
Current share price for SHL : $21.220 -0.27 (-1.26%)+
Announcement
Release
20 Nov 2025 8:59AM
Price at Release
$21.490
Full Release
download
Summary
During the 2025 Annual General Meeting, Sonic Healthcare Limited detailed its financial performance and strategic direction for the upcoming years. The company achieved an 8% increase in revenue and EBITDA for FY 2025, with significant contributions from its operations in the USA, Australia, Germany, and Switzerland. Key initiatives include targeted acquisitions like LADR in Germany and a focus on high-value medicine, which is driving growth and financial performance. Sonic aims to enhance shareholder value through disciplined capital allocation and efficiency improvements, particularly in pathology and laboratory services. Sustainability efforts were also highlighted, with a notable reduction in emissions and a commitment to renewable energy. The AGM included a forward-looking statement regarding FY 2026 guidance, projecting up to 13% EBITDA growth and continued investment in medical excellence and innovation.
Key Points
  • Sonic Healthcare achieved an 8% increase in revenue and EBITDA for FY 2025.
  • Key markets include the USA, Australia, Germany, and Switzerland.
  • Acquisition of LADR Laboratory Group in Germany is a strategic growth move.
  • The company emphasizes high-value medicine to drive growth.
  • Sonic focuses on enhancing shareholder value through disciplined capital allocation.
  • Sustainability initiatives include significant emission reductions and renewable energy commitment.
  • FY 2026 guidance projects up to 13% EBITDA growth.
  • Investment in medical excellence and innovation continues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.